SCHEMBL30833658

SCHEMBL30833658

CN1CCN(C2CCN(c3nn(C)c4cc([N+](=O)[O-])ccc34)CC2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 2/20 0.44
HRH3 Q9Y5N1 1/20 0.44
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
SIRT6 Q8N6T7 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
RHOA P61586 1/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 2/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
APP P05067 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
KCNH2 Q12809 1/20 0.38
LMNA P02545 1/20 0.38
HTR7 P34969 1/20 0.37
CDYL2 Q8N8U2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29190649 1.00 HRH4 (0.44) HRH4HRH3KMT2AMEN1SIRT6
SCHEMBL25598317 0.81 GAA (0.48) HRH4HRH3KMT2AMEN1L3MBTL1
SCHEMBL30833752 0.80 MEN1 (0.41) HRH4HRH3KMT2AMEN1SIRT6
SCHEMBL29190644 0.80 MEN1 (0.41) HRH4HRH3KMT2AMEN1SIRT6
SCHEMBL27756462 0.79 MAPT (0.47) KMT2AMEN1L3MBTL1ALDH1A1POLB
SCHEMBL25269885 0.76 DPP4 (0.43) L3MBTL1ALDH1A1MAPTSMN1; SMN2KCNH2
SCHEMBL25221087 0.76 DPP4 (0.43) L3MBTL1ALDH1A1MAPTSMN1; SMN2KCNH2
SCHEMBL30533985 0.76 DPP4 (0.43) L3MBTL1ALDH1A1MAPTSMN1; SMN2KCNH2
SCHEMBL4191910 0.75 SIRT6 (0.72) KMT2AMEN1SIRT6L3MBTL1ALDH1A1
SCHEMBL328462 0.75 WDR5 (0.49) KMT2AMEN1SIRT6ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113896744-B Selective EGFR inhibitor 成都先导药物开发股份有限公司 2024-04-16 CN disclosed